PIPELINE

Nirsum has developed a series of novel small molecule candidates with potential utility in OUD. Our most advanced compounds NRS-007, NRS-033, NRS-036 and NRS-063 are currently in lead selection in preparation for IND-enabling toxicology. Nirsum retains 100% ownership of its compounds.